Trials that use: Risk difference
New to this method? Read the tutorial →
4,772 results
- ACHIEVEIndependent statistical analysis of Albumin for Intracerebral Hemorrhage Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00990509).
- AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: Complete Statistical AnalysisIndependent statistical analysis of AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126187).
- ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: Complete Statistical AnalysisIndependent statistical analysis of ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ACT IIndependent statistical analysis of Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I): primary endpoint results,…
- ACTH Gel Therapy in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of ACTH Gel Therapy in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02030028).
- ACTHARIndependent statistical analysis of Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses: primary endpoint results, effect estimate with confidence interval, sample-size…
- ACTIV-6: COVID-19 Study of Repurposed Medications: Complete Statistical AnalysisIndependent statistical analysis of ACTIV-6: COVID-19 Study of Repurposed Medications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04885530).
- ACTIVATEIndependent statistical analysis of A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp: Complete Statistical AnalysisIndependent statistical analysis of Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ACTT-3Independent statistical analysis of ACTT-3, the phase 3 randomized trial of remdesivir plus interferon beta-1a versus remdesivir plus placebo in COVID-19, including time-to-recovery, subgroup hazard ratios, safety, and statistical interpretation.
- Acupressure in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Acupressure in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05412121).
- Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain: Complete Statistical AnalysisIndependent statistical analysis of Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01197950).
- Acute Headache Treatment in Pregnancy: Occipital Nerve Block vs PO Acetaminophen With Caffeine: Complete Statistical AnalysisIndependent statistical analysis of Acute Headache Treatment in Pregnancy: Occipital Nerve Block vs PO Acetaminophen With Caffeine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates: Complete Statistical AnalysisIndependent statistical analysis of Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda: Complete Statistical AnalysisIndependent statistical analysis of Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ADAMIndependent statistical analysis of A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage: Complete Statistical AnalysisIndependent statistical analysis of Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AdaProQuoIndependent statistical analysis of Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo: primary endpoint results, effect estimate with confidence interval, sample-size…
- ADAPTIndependent statistical analysis of ADAPT: Addressing Depression and Pain Together: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01124188).
- ADAPTIndependent statistical analysis of Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living: Complete Statistical AnalysisIndependent statistical analysis of Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer:…
- ADAPTSC+Independent statistical analysis of Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN: Complete Statistical AnalysisIndependent statistical analysis of ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04639024).
- Addressing Sexual Concerns in Breast Cancer: Patient Intervention Study: Complete Statistical AnalysisIndependent statistical analysis of Addressing Sexual Concerns in Breast Cancer: Patient Intervention Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03624972).
- Addressing Social Determinants of Health & Diabetes Self-Management in Vulnerable Populations: Complete Statistical AnalysisIndependent statistical analysis of Addressing Social Determinants of Health & Diabetes Self-Management in Vulnerable Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Addressing the Continuum of Care Among High-risk Thai Men: Complete Statistical AnalysisIndependent statistical analysis of Addressing the Continuum of Care Among High-risk Thai Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05161689).
- ADEPT1Independent statistical analysis of Observational Study of the LMA Protector: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03664700).
- ADHANDIndependent statistical analysis of A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy: primary endpoint results, effect…
- Adherence Assessment With Travalert Dosing Aid: Complete Statistical AnalysisIndependent statistical analysis of Adherence Assessment With Travalert Dosing Aid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00508469).
- Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine: Complete Statistical AnalysisIndependent statistical analysis of Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Adhese One F Upgrade in Direct Filling Therapy: Complete Statistical AnalysisIndependent statistical analysis of Adhese One F Upgrade in Direct Filling Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02175368).
- Adhesive Tape Placement on Patients’ Masks in the Emergency Department Increases Compliance of Proper Face Mask Use: Complete Statistical AnalysisIndependent statistical analysis of Adhesive Tape Placement on Patients' Masks in the Emergency Department Increases Compliance of Proper Face Mask Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ADIOSIndependent statistical analysis of Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02743520).
- Adipose-derived SVF for the Treatment of Knee OA: Complete Statistical AnalysisIndependent statistical analysis of Adipose-derived SVF for the Treatment of Knee OA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02726945).
- ADjoinIndependent statistical analysis of Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01206296).
- Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Administration of IV Laronidase Post Bone Marrow Transplant in Hurler: Complete Statistical AnalysisIndependent statistical analysis of Administration of IV Laronidase Post Bone Marrow Transplant in Hurler: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01173016).
- ADmIReIndependent statistical analysis of A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03831191).
- Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ADVANCEIndependent statistical analysis of Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02499679).
- Advance Cardiac Resynchronization Therapy (CRT) Registry: Complete Statistical AnalysisIndependent statistical analysis of Advance Cardiac Resynchronization Therapy (CRT) Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01805154).
- ADVANCE-2Independent statistical analysis of the ADVANCE-2 phase 3 trial of apixaban versus enoxaparin for prevention of thrombosis-related events following knee replacement surgery, including endpoint definitions, risk ratios, risk differences, sequential testing, bleeding…
- ADvantageIndependent statistical analysis of A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine: primary endpoint…